NEW HAVEN, Conn., Nov. 20, 2018 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a biotechnology company focused on advancing innovative therapies for neurological diseases, today announced that it will host its inaugural Annual Research & Development Day on...